BioCardia Inc 2025年季度报告

FORM10-Q/AAmendment No. 1 (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedJune 30, 2025 or TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number:001-38999! BioCardia, Inc.(Exact name of registrant as specified in its charter) 320 Soquel WaySunnyvale,California94085(Address of principal executive offices including zip code) (650)226-0120(Registrant’s telephone number, including area code) N/A(Former name, former address and former fiscal year, if changed since last report) Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject tosuch filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, oran emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule 12b-2 of the Exchange Act. Largeacceleratedfiler☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ Securities registered pursuant to Section 12(b) of the Act: Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. There were5,801,224shares of the registrant’s Common Stock issued and outstanding as of August 8, 2025. EXPLANATORY NOTE AMENDMENT OF QUARTERLY REPORT SOLELY BECAUSE PRINCIPALOFFICER CERTIFICATIONS WERE INADVERTENTLY OMMITTED IN THEORIGINAL FILING This Amendment No. 1 to the Quarterly Report on Form 10-Q/A (the Amendment) amends our Quarterly Report on Form10-Q filed on August 11, 2025 (the Original Filing) which inadvertently omitted the Exhibit 32.1 and Exhibit 32.2Certifications of the Principal Executive Officer and the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (the Certifications). The Certifications are includedwith this Amendment. With the exception of the inclusion of the Certifications and currently dated certifications of theCompany’s Principal Executive Officer and Principal Financial Officer as required by Section 302 of the Sarbanes OxleyAct of 2002, there were no changes to the Original Filing. All references to the Form 10-Q in this Report shall refer to thisForm 10-Q/A. Except as described above, this Amendment does not amend, update or change any other items or disclosures in theOriginal Filing and does not purport to reflect any information or events subsequent to the filing of the Original Filing. Assuch, this Amendment only speaks as of the date the Original Filing was filed, and we have not undertaken herein toamend, supplement or update any information contained in the Original Filing to give effect to any subsequent events.Accordingly, this Amendment should be read in conjunction with the Company’s filings made with the SEC subsequent tothe filing of the Original Filing, including any amendments to those filings. Item 1.Unaudited Condensed Consolidated Financial Statements6Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 20246Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2025 and 20247Condensed Consolidated Statements of Stockholders’Equity (Deficit) for the three and six months ended months ended June 30,2025 and 20248Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 20249Notes to Unaudited Condensed Consolidated Financial Statements10Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations17Item 3.Quantitative and Qualitative Disclosures About Market Risk24Item 4.Controls and Procedures24 Part II.OTHER INFORMATION25 Item 1.Legal Proceedings25Item 1A.Risk Factors25Item 2.Unregistered Sales of Equity Securities and Use of Proceeds25Item 3.Defaults Upon Senior Securities25Item 4.Mine Safety Disclosures25Item 5.Other Information25Item 6.Exhibits26